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ABSTRACT: Quantifying the chemical composition of un-
stained intact tissue and cellular samples with high spatio-
temporal resolution in three dimensions would provide a step
change in cell and tissue analytics critical to progress the ﬁeld of
cell biology. Label-free optical microscopy oﬀers the required
resolution and noninvasiveness, yet quantitative imaging with
chemical speciﬁcity is a challenging endeavor. In this work, we
show that hyperspectral coherent anti-Stokes Raman scattering
(CARS) microscopy can be used to provide quantitative
volumetric imaging of human osteosarcoma cells at various
stages through cell division, a fundamental component of the cell cycle progress resulting in the segregation of cellular content
to produce two progeny. We have developed and applied a quantitative data analysis method to produce volumetric three-
dimensional images of the chemical composition of the dividing cell in terms of water, proteins, DNAP (a mixture of proteins
and DNA, similar to chromatin), and lipids. We then used these images to determine the dry masses of the corresponding
organic components. The attribution of proteins and DNAP components was validated using speciﬁc well-characterized
ﬂuorescent probes, by comparison with correlative two-photon ﬂuorescence microscopy of DNA and mitochondria.
Furthermore, we map the same chemical components under perturbed conditions, employing a drug that interferes directly with
cell division (Taxol), showing its inﬂuence on cell organization and the masses of proteins, DNAP, and lipids.
Optical microscopy is the most used technique for imaginglive and ﬁxed cells and tissues with subcellular spatial
resolution. Fluorescence based methods are typically em-
ployed, which generally require labeling to provide speciﬁc-
ity,1−3 and are widely utilized to study processes such as
protein localization, interactions and cell metabolism.4
However, these techniques are innately invasive and can lead
to ﬂuorophore photobleaching and associated phototoxicity.
Fluorescence staining also adds to the complexity of sample
preparation, both for synthetic and genetically encoded
ﬂuorophores, and the potential for chemical/structural
modiﬁcations of the sample undermines the experimental
rationale of observing biological specimens in a nonperturbing
way. Furthermore, the quantitative interpretation of ﬂuores-
cence intensities in terms of the amount of labeled material is
hindered by the complexity of the staining process and
photobleaching.
As alternative to ﬂuorescence microscopy, label-free
chemical sensitivity and high spatial resolution are provided
by Raman scattering microscopy,5 interrogating the vibrational
resonances of endogenous molecules. However, spontaneous
Raman scattering provides only weak signals, mandating long
integration times and/or high excitation powers, limiting the
applicability of the technique to imaging biological specimens.
Speciﬁcally it is not suitable for live cells with cellular
compartments that can move on a subsecond scale. Although
recent developments toward light-sheet Fourier-transform
Raman imaging6 have the potential to improve the acquisition
speed, Raman microscopy is also aﬀected by autoﬂuorescence
background, which limits its present applicability to volumetric
imaging and makes it incompatible with ﬂuorescent labeling.
Higher signals can be achieved in coherent Raman scattering
(CRS), a nonlinear optical technique in which molecular
vibrations are driven coherently by a light intensity
modulation, typically achieved by the interference of two
laser beams of diﬀerent wavelengths. The signal enhancement
in CRS originates from the coherent superposition of the
Raman scattered ﬁelds, with a factor given by the number of
vibrational modes in the focal volume, which can reach 1010 for
pure materials such as lipids.7 CRS can be measured as
Received: October 13, 2018
Accepted: January 9, 2019
Published: January 9, 2019
Article
pubs.acs.org/acCite This: Anal. Chem. XXXX, XXX, XXX−XXX
© XXXX American Chemical Society A DOI: 10.1021/acs.analchem.8b04706
Anal. Chem. XXXX, XXX, XXX−XXX
This is an open access article published under a Creative Commons Attribution (CC-BY)
License, which permits unrestricted use, distribution and reproduction in any medium,
provided the author and source are cited.
D
ow
nl
oa
de
d 
vi
a 
CA
RD
IF
F 
U
N
IV
 o
n 
Ja
nu
ar
y 
30
, 2
01
9 
at
 0
9:
23
:2
5 
(U
TC
). 
Se
e 
ht
tp
s:/
/p
ub
s.a
cs
.o
rg
/sh
ar
in
gg
ui
de
lin
es
 fo
r o
pt
io
ns
 o
n 
ho
w
 to
 le
gi
tim
at
el
y 
sh
ar
e 
pu
bl
ish
ed
 a
rti
cl
es
. 
coherent anti-Stokes Raman scattering (CARS)8 or stimulated
Raman scattering (SRS),9 both having their advantages and
drawbacks.7,10−12 CARS is generally easier to implement
experimentally, since it occurs at a diﬀerent wavelength
compared to that of the exciting beams; thus, the signal can
be easily separated via an optical bandpass ﬁlter and is blue-
shifted compared to the one-photon excited ﬂuorescence
background. On the other hand, it requires a more in depth
data analysis, due to the contribution of vibrationally
nonresonant backgrounds. Speciﬁcally, the CARS intensity
can be described as IC ∝ |χ|2 = |χR + χNR|2, where χR (χNR) is
the vibrationally resonant (nonresonant) component of the
third-order susceptibility corresponding to the CARS process.
χR has both real and imaginary parts, while χNR is due to an
electronic contribution and is real for materials without two-
photon absorption, which is the case for water, proteins, DNA,
and lipids, for excitation pulses with wavelengths in the
biological window,7 700−1300 nm. Therefore, one can rewrite
9χ χ χ χ∝ | | + + | |I 2 ( )C R
2
R NR NR
2. The imaginary component
of the resonant CARS susceptibility, i.e., 1 1χ χ=( ) ( )R
resembles the spontaneous Raman scattering cross-section,
having peaks at the vibrational frequencies, and is linear in the
concentration of the detected chemical species; therefore, it is
the quantity of interest to be extracted from the measured
CARS intensity. The challenge in retrieving 1 χ( ) from the
CARS intensity is the determination of the phase of χ. On the
other hand, the presence of the nonresonant contribution is
also an advantage, as it enhances the intensity of weak χR by
the homodyning in the interference term 9 χ χ2 ( )R NR , and it
allows a nonresonant material to be used as reference for
quantitative analysis.13 For the phase retrieval, eﬀectively
equivalent techniques14 in current use are based on a time-
domain Kramers−Kronig (KK) formulation15 and the
maximum entropy method.16 We have recently developed a
phase-corrected KK approach (PCKK) which is improving on
the KK formulation, by correcting not only the phase but also
the amplitude of the signal, and results in a quantitative
susceptibility in units of χref, relative to a known nonresonant
reference material, χ̅ = χ/χref.
17 Glass can be used as a reference
material for frequencies above 1200 cm−1 and is convenient
since it is typically part of the sample mount. For a larger
frequency range, NaCl is a suitable choice as reference.13
Once the complex susceptibility is obtained, the resulting
hyperspectral images still need to be analyzed in terms of the
physical quantity of interest, which is the chemical composition
of the specimen in terms of spatially resolved concentration
maps of separated chemical components. Diﬀerent techniques
toward this goal have been proposed in literature, including
classical least-squares analysis,18 independent component
analysis,19 and multivariate curve resolution analysis.20 We
have developed an algorithm to analyze CARS hyperspectral
images which determines quantitative spectra and absolute
concentration images of separate chemical components
without prior knowledge, called FSC3 (factorization into
spectra and concentrations of chemical components).17,21 In
this method the hyperspectral data are factorized as D = ∑iCi
× Si + E, with Ci and Si being the non-negative concentration
distribution and spectrum of the ith component, respectively,
and E is the error, the norm of which is minimized. This
method was recently used to quantitatively measure the lipid
uptake in human adipose derived stem cells,22,23 to investigate
the diﬀerentiation of stem cells,24 and toward high-throughput
imaging using a Bessel beam and sparse sampling.25 It was also
shown to be suited for the quantitative determination of the
absolute volume of chemical components in three-dimensional
imaging, using polystyrene beads as proof-of-principle.13 These
studies opened the prospect of quantifying the volumetric
chemical composition of intact unstained biological cells with
submicron spatial resolution.
The cell cycle, a fundamental process underlying the
proliferation of cell populations, broadly comprises two stages:
interphase and cell division or mitosis. The cell division
comprises various distinct stages in which the genetic material
and organelles become segregated between the two progeny or
daughter cells.26,27 As the cell progresses through these stages,
the cell volume,28 chromatin density,29 and distribution/
number of organelles change.30,31 Quantitative mapping of
these changes is key to the fundamental understanding of cell
division and its monitoring in biomedically relevant
applications. Traditionally, studies of the regulation and
control of mitosis have been conducted using ﬂuorescence
labeling of cell organelles and small biomolecules. For instance,
the Mitocheck consortium undertook phenotypic proﬁling
using ﬂuorescence timelapse microscopy to understand the
critical genes responsible for cell division.32 Recently, label-free
but chemically nonspeciﬁc quantitative phase contrast imaging
was developed to study the change of the cell mass during the
cell cycle.33−35
In the present paper, we demonstrate the application of
volumetric quantitative hyperspectral CARS microscopy to
image cells in three dimensions. We determine changes in the
masses of cell components resembling proteins, a mixture of
DNA and proteins, which we call here DNAP, and lipids at
diﬀerent stages of mitosis. As an outlook toward more
biomedically relevant studies, we then apply this quantitative
imaging to investigate the eﬀect of an anticancer drug, Taxol,
which stabilizes microtubule spindle structure and triggers the
spindle-assembly checkpoint to halt the cells in metaphase.36
■ MATERIALS AND METHODS
In this study we used human osteosarcoma cells [U-2 OS]
(ATCC HTB-96) transfected with a G2 M Cell Cycle Phase
Marker (GE Healthcare, U.K.). The preparations were ﬁxed,
capturing a heterogeneous population transitioning through
interphase and mitosis. Diﬀerent sample preparations were
produced to enable combined ﬂuorescence and CARS
modality for validation purposes and further to determine
the consequences of drug perturbation. The two ﬂuorescent
molecular probes used have good two-photon cross-sections:
(i) Mitotracker Orange diﬀuses across the plasma membrane
of a live cell by passive transport and accumulates in the
mitochondria37 and (ii) DAPI (4′,6-diamidino-2-phenyl-
indole) binds to the minor groove of DNA, speciﬁcally the
adenine and thymine rich regions of the DNA.38 Details on the
sample preparation are given in the Supporting Information
(SI), section 1.
The data presented in this work were acquired on a home-
built multimodal inverted microscope setup13,39 built around a
Nikon Ti-U. Details are given in the SI, section 2. An example
of DIC microscopy used to select cells for imaging with CARS
is given in the SI, section 3. The hyperspectral CARS images
were analyzed using the hyperspectral image analysis (HIA)
software developed in our group,13,17,21 which retrieves the
complex resonant susceptibility χ̅ relative to a glass reference.
The volumetric images of χ̅ are then factorized into
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susceptibilities and concentrations of chemical components via
FSC3 which is using a non-negativity constrain on concen-
trations and the imaginary part 1 χ ̅( ) as well as the spectrally
averaged real part 9 χ⟨ ̅ ⟩( ) of the component spectra. Unless
otherwise speciﬁed, the CARS intensity data were taken over
the spectral range 2600−3600 cm−1, and the susceptibility χ̅
was retrieved over this range and analyzed using FSC3 over the
spectral range 2750−3200 cm−1. Above 3200 cm−1, χ̅ is
dominated by the OH stretching vibrational resonances of
water, which was excluded from the FSC3 analysis to reduce
the inﬂuence of systematic errors in the dominating water
component; note that the imaged volume contains about 95%
water. For comparison, the FSC3 analysis of the cell in
prometaphase over 2650−3600 cm−1 including the water
resonance is shown in the SI, section 6i.
■ RESULTS AND DISCUSSION
CARS and TPF Imaging. We show here examples of U-2
OS cells in prometaphase, anaphase, and telophase. Figure 1
gives an overview of the FSC3 analysis for a cell in
prometaphase (just before chromosome alignment). The
factorization uses the full data containing ∼106 voxels to
retrieve components, resulting in well deﬁned spectra with low
noise, as shown in Figure 1g. For this analysis, we found that at
least seven components in the FSC3 were required (see the
Materials and Methods section and the SI). The components
shown resemble protein (* *≡1 P), DNAP (* *≡2 D), and
lipids split into lipid droplets (* *≡3 LD) and lipid membranes
(* *≡4 LM), attributed according to their spatio-spectral
proﬁles. The other components are water (*5 and *6) and
glass (*7; see the SI, Figure S21). We note that due to spectral
similarities and low concentration of nonlipidic organic
material in the cells, we do not obtain pure components for
protein and DNA. On the other hand, lipid spectra are better
distinguished, identiﬁed by their abundance of C−H bonds.
Furthermore, lipids, if not part of membrane structures, are
segregated into lipid droplets and thus form localized, highly
concentrated chemical species which can be identiﬁed readily
in FSC3.
Considering the lipid components, we observe that *LM is
localized at the cell membrane, having a smaller 1 χ ̅( ) than
that of *LD, which is localized in lipid droplets, with a weak
contribution at the cell boundary. *D is located in the
chromosomal region, and *P is distributed across the cell,
including the chromosomal region where it shows some
colocalization with *D. This is not surprising, as both
components contain protein. Note that in this paper we refer
to the region containing the DNA as the chromosomal region,
as during mitosis the nuclear compartment is not present. In
addition to the FSC3 components, we deﬁne a sum water
component *W (Figure 1W) by combining the water
components C5 and C6 with a concentration given by the
sum of the concentrations and a spectrum given by the average
of the spectra weighted by their mean concentration over the
imaged volume. Furthermore, we show in Figure 1a the total
concentration of water CTW = ∑Ciγiw, calculated by adding all
of the component concentrations weighted with their water
fractions γi
w. The latter is deduced from the dry fractions γi
d as
Figure 1. FSC3 concentrations and spectra of a U-2 OS cell in prometaphase. Images are xy and xz sections, given on a grayscale as shown from 0
to a maximum value indicated below each image. W, 1, 2, 3, 4 show the concentrations CW,1,2,3,4 of the respective components. Components 1 to 4
are also labeled P, D, LD, and LM, respectively, according to their chemical attribution. The corresponding maximum dry v/v concentration is
given in parenthesis. The arrows indicate the respective positions of the sections. Panel a shows the total concentration of water CTW. Panels b and c
show the photoelectron rate in units of photoelectrons per second detected by the photomultiplier of TPF of DAPI and Mitotracker-orange,
respectively. Panel d is a color overlay of C2 in red and DAPI TPF in blue. Panel e shows C1 in green and Mitotracker TPF in red. The PCKK
spectra taken at the color coded points marked on W are given in panel f. Panel g shows the spectra of the FSC3 components as labeled. Dashed
lines show spectrally averaged 9 χ ̅( ), and solid lines represent 1 χ ̅( ). Corresponding 3D data are provided in the ref 40
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γi
w = 1 − γid. The dry fractions γid are calculated as described
later and are given in Table 1. We ﬁnd γ1
w = 0.639, γ2
w = 0.942,
γ3
w = 0.623, γ4
w = 0.965, γ5
w = γ6
w = 1.00, and γ7
w = 0. CTW shows a
homogeneous distribution across the cell close to unity, with a
slightly negative contrast in the regions corresponding to the
lipid and DNAP components, having a concentration of dry
mass within the PSF up to about 20%. The retrieved spectra, at
the three points color coded in the *W map, are given in
Figure 1f and reveal small spectral diﬀerences, in the range of
0.1 in 1 χ ̅( ) . This is much smaller than 1 χ ̅( ) of bulk lipid
having a peak value17 of about 6, reﬂecting the small
concentration of organic material in the focal volume. 3D
data in the form of movies for the concentration maps of the
chemical components are available online (see data in ref 40).
Results from TPF microscopy and their comparison with the
FSC3 analysis of CARS images is shown in Figure 1b−e, and
their correlation is analyzed in the SI, section 5. Good
colocalization of *D (red) with DAPI TPF (blue) is observed
in Figure 1d. *P (green) and Mitotracker-orange TPF (red)
shown in Figure 1e are not signiﬁcantly colocalized. *LM
indicates some colocalization with the Mitotracker-TPF,
supporting the attribution of *LM to lipid membranes which
are dense in mitochondria. This ﬁnding suggests that
mitochondria are detected in FSC3 not as a separated chemical
component but as part of the protein *P and lipid membrane
*LM components.
Figure 2 shows the volumetric imaging of a cell in anaphase,
which has been analyzed with FSC3 together with the cell in
prometaphase shown in Figure 1. The genetic material (*D) is
distributed at the two poles of the oval shaped cell (visible in
the concentration map of *P). These are characteristic features
of cells in anaphase. *LD shows small lipid droplets alongside
an extracellular and membrane background, while *LM appears
with a cell background also showing some lipid aggregates/
droplets. Furthermore, we observe only a partial polarization of
the lipid components which appear to be concentrated in the
top half of the cell, indicating their nondesignation to either of
the future daughter cells. We note good correlation between
*D and DAPI TPF, while *P and Mitotracker TPF show a
smaller degree of colocalization, consistent with the ﬁndings
for the cell in prometaphase.
In Figure 3, the volumetric imaging of two future daughter
cells in telophase is shown, analyzed together with the cells in
prometaphase and anaphase (i.e., all retrieved component
spectra are in common). We note a slightly asymmetric
cytoplasmic cleavage along the vertical (y) direction.
Furthermore, the chromosomal material is split into two
parts, as shown by *D. The nuclear membranes are still lacking,
typical of cells in telophase. The lipid droplets are clearly
visible in *LD, with a general background in the imaged
volume. We note that *LM has a negligible concentration in
Table 1. Volumes and Masses of *1, *2, *3, and *4 of
Labelled U-2 OS Cells in Various Stages of Mitosis, over the
Chromosomal and Cell Volumesa
i type γi
d Vi (μm
3) Vi/VROI (%) Mi (pg)
Figure 1 - prometaphase - chromosomal volume - 982 μm3 (20%)
1 P 0.361 32.5 ± 0.3 3.31 42.3 (43.2)
2 D 0.058 1.2 ± 0.6 0.13 1.9 (0.9)
3 LD 0.377 1.81 ± 0.05 0.18 1.6
4 LM 0.035 1.8 ± 0.1 0.18 1.6
Figure 1 - prometaphase - cell volume - 4944 μm3
1 P 0.361 133 ± 1 2.70 173.5 (177.3)
2 D 0.058 3.1 ± 0.6 0.06 4.7 (0.9)
3 LD 0.377 17.8 ± 0.5 0.36 16.0
4 LM 0.035 11.2 ± 0.2 0.23 10.0
Figure 2 - anaphase - chromosomal volume - 675 μm3 (14%)
1 P 0.361 17.6 ± 0.2 2.61 22.9 (24.7)
2 D 0.058 1.1 ± 0.6 0.17 1.7 (−0.1)
3 LD 0.377 0.84 ± 0.02 0.12 0.8
4 LM 0.035 6.2 ± 0.1 0.91 5.5
Figure 2 - anaphase - cell volume - 4788 μm3
1 P 0.361 74.4 ± 0.7 1.55 96.7 (104.3)
2 D 0.058 5.0 ± 0.6 0.11 7.5 (−0.1)
3 LD 0.377 12.2 ± 0.3 0.25 10.9
4 LM 0.035 42.3 ± 0.6 0.88 37.8
Figure 3 - telophase - chromosomal volume * - 317 μm3 (11%)
1 P 0.361 18.1 ± 0.2 5.72 23.6 (24.3)
2 D 0.058 0.4 ± 0.6 0.13 0.6 (−0.04)
3 LD 0.377 1.04 ± 0.03 0.33 0.9
4 LM 0.035 0.04 ± 0.1 0.01 0.04
Figure 3 - telophase - cell volume* - 2802 μm3
1 P 0.361 87.5 ± 0.9 3.12 113.7 (117.0)
2 D 0.058 2.1 ± 0.6 0.08 3.2 (−0.04)
3 LD 0.377 17.1 ± 0.5 0.61 15.3
4 LM 0.035 0.5 ± 0.1 0.02 0.5
aThe percentage of chromosomal to cell volume is indicated. The
telophase results are per cell. The rebalanced masses M̃P and M̃D are
given in parentheses.
Figure 2. FSC3 analysis and TPF imaging of a U-2 OS cell in anaphase. Images are xy and xz sections. W, 1, 2, 3, 4 show concentrations CW,1,2,3,4 of
the respective components with spectra as shown in Figure 1g on a grayscale as in Figure 1. Panels a and b show the detected photoelectron rate of
TPF of DAPI and of Mitotracker-orange, repectively. Panel c is a color overlay of C2 in red and DAPI TPF in blue. Panel d is a color overlay of C1
in green and Mitotracker TPF in red.
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these cells. As observed for the cells in prometaphase and
anaphase, the concentration distribution of *D is correlated
with DAPI TPF, and *P and *LM are correlated with
Mitotracker TPF. The FSC3 components not shown in Figures
2 and 3 are given in the SI, in Figures S22 and Figure S23,
respectively.
Volume and Mass Analysis. The quantitative capability
of hyperspectral CARS imaging analyzed with FSC3 was
demonstrated using beads of pure material.13 Here, we use this
capability to quantify the volumes and dry masses of individual
chemical components of cells in mitosis. Notably, this analysis
is challenging due to the small volume fraction of organic
material in the cells.
Calculation of Dry Fractions. The FSC3 components
typically contain a signiﬁcant fraction of water, as can be seen
in their spectra (Figure 1g), showing a rising 1 χ ̅( ) in the
3100−3200 cm−1 range. This is expected, given that these
components are used to describe data with a maximum dry
concentration over the PSF well below unity. Therefore, in
order to quantify the dry masses of the various components, we
have to remove the water contribution. For IFDs above 3100
cm−1 we can assume that 1 χ ̅( ) is dominated by the water
component, while the organic components have signiﬁcant
1 χ ̅( ) in the range 2800−3100 cm−1.
We remove the contribution of water to the spectra by
subtracting a fraction α of the water spectrum 1 χ ̅( )W ,
resulting in the dry spectrum 1 1 1χ χ α χ̅ = ̅ − ̅( ) ( ) ( )dry W ,
where α is chosen to result in 1 χ ̅( )dry of zero at the upper
limit of the IFD range analyzed by FSC3, where 1 χ ̅( )W is
highest. The values of α and the corresponding spectra are
given in the SI, section 9.
The dry volume fraction γi
d of an FSC3 component *i is then
taken as the ratio of the integral Ai of 1 χ ̅( )dry over the CH
stretch region to the corresponding integral Adry of the dry bulk
material of the component. The latter is estimated as Adry =
AOAFi using the integral AOA of a measured pure dry material
which is available, here oleic acid (OA). The factor Fi is
calculated assuming that the integral is proportional to the
volume density of −H bonds in the material with vibrational
frequencies in the integration range. This factor can therefore
be expressed as
ρ
ρ
=F b
b
m
mi
i
i
i
OA
OA
OA (1)
where bOA (bi) is the number of Raman active bonds in a
molecule of OA (*i) in the IFD range considered, mOA (mi) is
the molecular weight of OA (*i) and ρOA (ρi) is the mass
density of OA (*i), respectively. The corresponding values are
given in the SI, in Table S2 for protein, DNA, and common
lipids in cells, palmitic acid (PA) and stearic acid (SA),41 as
well as OA. In the calculation of these factors, for protein, the
relative abundance of twenty amino acids42 which make up
proteins was taken into account. DNAP, using chromatin as a
model, was considered to be a mixture of protein and DNA in
a 2:1 ratio.43 Furthermore, the four constituent bases of DNA
were assumed to occur in equal numbers.
For lipids, F3 = F4 = 1.0 was calculated using an average of
the OA, PA, and SA densities,44−46 which is equal to the
density of oleic acid, ρOA = 0.895 g/cm
3. For bulk OA, the
integral AOA = 797 cm
−1 of 1 χ ̅( ) over the IFD range 2650−
3100 cm−1 was measured. We calculate the density of DNAP
as 1.5 g/cm3 using the protein density, 1.3 g/cm3, and the
DNA density,47 2 g/cm3. For protein (*1) we ﬁnd F1 = 0.58.
For DNA, this factor is 0.53, so that for DNAP, F2 = 0.56 is
calculated using a weighted average of factors for protein and
DNA in a 2:1 ratio. We note that the Fi for protein and DNAP
are about half that of lipid, reﬂecting the lower abundance of
hydrogen in these materials. Further discussion of the accuracy
of this procedure is given later.
Volumes of the Dry Components. Volume calculations
to estimate the mass of the organic FSC3 components in the
cells were made in two diﬀerent regions of interest (ROI): the
chromosomal region and the whole cell. To deﬁne the
chromosomal ROI, we thresholded the corresponding TPF-
DAPI images, and the cell ROI was determined using the cell
perimeter visible in *P. The dry volumes Vi and masses Mi of
the FSC3 components *i were then calculated as volume
integrals
∫γ ρ= =V C V M V(r) d andi id i i i iROI (2)
with the three-dimensional position r. The results of these
volumetric calculations over the chromosomal and cell ROIs
are given in Table 1. The errors given for Vi are accounting for
the error in Ai due to the selection of α and the ﬂuctuations in
the spectra. The dry volumes reported for the cells in telophase
Figure 3. As in Figure 2 but for a cell pair in telophase. This data was
acquired over the IFD range (2600−3800) cm−1 with step size 6
cm−1.
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are given as average per daughter cell. From here onward, we
will indicate such reference by an asterix * for all ﬁelds of view
comprising more than one cell.
The results in Table 1 show cell dry masses in the 100−200
pg range. Most of this is protein, supplemented by about 10%
lipids in droplets in *LD and a similar amount of lipids in
membranes in *LM. Over the chromosomal volumes, we
observe, as expected, low levels of lipids. Additionally, the
composition of the chromosomal region is dominated by the
protein component *P. The DNAP component *D amounts to
a few percent of the cell dry mass, about 1.8 pg in
prometaphase and anaphase and 0.6 pg after division in
telophase. We would expect the chromosomal content to split
in equal parts into the two daughter cells and, therefore, expect
a mass of 0.9 pg in telophase, which is consistent with the
measurements within error. However, these DNAP masses are
at the limit of detection (see error values) and signiﬁcantly
lower than the known DNA content of a diploid cell, which is
5−7 pg before and 10−14 pg after the S phase.43 We note that,
if DNAP is assigned to pure DNA, the mass would increase by
a factor of 1.37 due to the higher density. Furthermore, due to
the spectral similarities of DNA with protein, which has a
higher concentration in the cell, some of the DNA could be
contributing to *P. Therefore, we examine the sum of the
masses of protein and DNAP components in the chromosomal
region, which is about 44.2 pg for the prometaphase, 24.6 pg
for the anaphase, and 24.2 pg for each of the telophase cells.
This is in good agreement with the expectation that the mass
of chromatin in mitotic cells (with double the DNA content
compared to a diploid G1 cell) would vary between 30 and 42
pg, considering 10 to 14 pg of DNA per mitotic cell, and the
mass ratio of protein:DNA (2:1) in chromatin. The
factorization of the cell composition into only few components
thus provides masses corresponding to protein and DNAP
within the chromosomal region in all three cells, in agreement
within error with the literature values of chromatin mass in a
cell. With respect to the lipid composition of the cell, we
observe most of the lipids (*LD and *LM) outside of the
chromosomal region.
In an attempt to better separate the mass of DNA from
proteins, we can use the prior knowledge that the DNA mass
outside of the nuclear region is zero. We deﬁne accordingly
rebalanced masses of protein, M̃P = MP + βMP and DNAP, M̃D
= MD − βMP, where β = MD/MP with the DNAP mass MD and
protein mass MP in the extra-chromosomal region, so that M̃D
= 0 in this region, as required. The resulting rebalanced masses
are given in parentheses in Table 1. We observe, for this
factorization, a M̃D of zero within error in anaphase and
telophase cells, showing that DNA is not fully separated from
other protein components in the present data and also that the
DNA mass is close to the detection limit. It is also possible that
the determination of the DNA mass is aﬀected by the DAPI
staining, since, as will be shown later, for the unlabeled
drugged cells the rebalanced masses are in agreement with the
expected DNA mass.
An interesting feature of cell division is chromosome
compaction, which is still not fully explained. A major
challenge in these studies is related to the use of ﬂuorophores
and the associated analysis with variable results depending on
the speciﬁc measurement and analysis methods used.29 CARS
can contribute results to such studies because of its
noninvasive high resolution chemical speciﬁcity. Considering
the volume ROIs, we observe that the ratio of chromosomal to
cell volume decreases from prometaphase (20%) to anaphase
(14%) to telophase cells (11%), indicating progressing
chromatin compaction. At the same time, the ratio of
chromosomal to cell protein and DNAP masses changes
much less from 25%, to 24%, to 21%, quantifying the
chromosome compaction.
The reproducibility of the analysis against random initial
guesses for spectra and concentrations in the FSC3
factorization is discussed in the SI, section 7 through an
alternative simultaneous factorization of the three data sets. We
ﬁnd that mass and volume for the dominant protein
component have a relative systematic error of around 10%.
Changes are more signiﬁcant for chemical species with small
dry fractions and low signal-to-noise ratios such as DNAP. To
investigate the reproducibility for cells of equal stage, we have
analyzed a second prometaphase cell (see the SI, Figure S10),
showing consistent results. The factorization can be guided to
provide more reproducibility, as will be used below. Further
discussion of systematic errors in dry mass determination is
given in the SI, section 10.
U-2 OS Cells Treated with the Anticancer Drug Taxol.
The ability of an imaging technique to quantify changes in the
intracellular chemical composition following drug treatment is
of great importance to understand the eﬀects of drugs at a
subcellular level and to assess the treatment consequences
(pharmacodynamics). With this goal in mind, we explore here
the application of quantitative CARS microscopy to cells
treated with the anticancer drug Taxol, which promotes
polymerization of tubulin, thereby causing an arrest in
Figure 4. FSC3 analysis of a Taxol treated U-2 OS cell. Images W, 1, 2, 3 show xy and xz sections of concentrations of the components *W ,1,2,3 with
spectra given in panel a. Grayscales are as in Figure 1. This data was acquired with z step size of 1 μm and an IFD range of 2600−3800 cm−1.
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metaphase which usually downstream leads to apoptosis.48 At
low concentrations, Taxol interferes with microtubule
dynamics and prevents the attachment of kinetochores to the
spindle apparatus resulting in cell cycle arrest in metaphase by
activation of the spindle assembly checkpoint.49 We performed
hyperspectral CARS measurements and FSC3 analysis on
Taxol treated U-2 OS cells. To promote reproducibility of the
factorization, we took a systematic approach where a guided
FSC3 was used in which a set of voxels with a priori chosen
spectra are added to the data to form guides which “suggest” to
the factorization algorithm the component spectra while not
constraining it. The weights w of the guide spectra deﬁne the
relative volume of the guides with respect to the data being
analyzed. Three guide spectra (SI, Figure S15) were obtained
by factorizing the composition of a control cell (SI, Figure
S16). We also lowered the upper limit of the IFD range to
3150 cm−1 to reduce the inﬂuence of the water in the
factorization from which these guides were obtained.
Two Taxol treated cells were factorized simultaneously using
the IFD range (2750−3150) cm−1 and w ≈ 4% for each of the
guide spectra. One of the cells in this analysis is shown in
Figure 4. * *≡1 P, representing proteins, is homogeneous over
the cell, with slightly negative contrast in the nuclear region. In
* *≡2 D, representing DNAP, we see a linear distribution of
chromosomes in the equatorial plane of the cell, which appears
misaligned in the midleft region of the cell. This is a known
characteristic eﬀect of Taxol.50 The lipid component
(* *≡3 L) is localized at the cell membranes and lipid
droplets. This factorization was using nine FSC3 components,
with the additional components corresponding to water, glass,
and systematics given in the SI, Figure S32. The other Taxol
treated cell showing circularly arranged *D is shown in the SI,
Figure S14.
Volumetric calculations over the chromosomal region and
the whole cell as described previously were performed on this
cell, and the results are given in Table 2. The parameters of this
calculation are given in the SI, Figure S20. Since Taxol arrests
cells in metaphase, we compare the results of this factorization
with the untreated prometaphase cell shown earlier. First, we
note that the chromosomal and cell volumes of the Taxol
treated cells we measured are similar to the prometaphase cell.
Also, similar to the analysis for the labeled cells, here too we
note a distribution of *D outside the chromosomal volume.
Therefore, we consider the rebalanced component masses. In
the chromosomal region, the resulting *D mass is consistent
with the expected diploid DNA mass of 10−14 pg, while *L
has a mass approximately 6 times larger than in the
prometaphase cell shown earlier. This could indicate that
Taxol not only results in a misalignment of chromosomes, a
known eﬀect, but also in the accumulation of lipid vesicles in
the chromosomal region. This is a plausible outcome of the
drug treatment, because it is known that the organelles
fragment and aggregate on the stabilized microtubule spindle.
Generally, over the cell volumes, we observe a higher lipid
mass in Taxol treated cells compared to the untreated samples.
This is consistent with the known hypertriglyceridimic eﬀect of
Taxol and cis-platin based chemotherapy.51 Considering the
protein component *P over the cell volume, we note that its
density (mass/cell volume) is double compared to the
untreated prometaphase cell, in line with the hyperproteic
eﬀect of Taxol reported in literature.52
■ CONCLUSIONS
In this paper, we have demonstrated a method for unbiased
quantitative chemically speciﬁc volumetric CARS microscopy
on individual ﬁxed U-2 OS cells and determined the
intracellular dry masses of protein, DNAP, and lipid
components. The attribution of proteins and DNAP chemical
components was supported by comparison with correlative
two-photon ﬂuorescence imaging of Mitotracker-orange and
DAPI staining. We investigated untreated cells during mitosis,
and cells treated with the anticancer drug Taxol. The results
are consistent with biomolecular changes expected during
mitosis and the eﬀects of drug treatment. In particular, cells
treated with Taxol appear chemically similar to untreated
samples, while containing a somewhat larger amount of
proteins and lipid, a known eﬀect of Taxol based chemo-
therapy. Moreover, the morphology of the nuclear material
(DNAP) and its intracellular distribution in Taxol treated cells
are characteristically diﬀerent from those of control samples.
Generally, this work shows that CARS microscopy, tradi-
tionally utilized to study highly dense lipid aggregates, can
provide quantitative chemical speciﬁcity and sensitivity in the
detection of proteins and nuclear components in not lipid-rich
cells where the imaged volume contains mostly water. Since
CARS microscopy is a label-free tool applicable to unmodiﬁed
samples, the progress shown here paves the way toward
quantitative volumetric image analysis of proteins, lipids, and
DNA in intact living cells. We note that while the PFA ﬁxation
used in the present work is known to have little inﬂuence on
the cell mass and Raman spectra, as discussed in the SI, section
4, the logical next step will be live cell imaging as it allows the
dynamics of components to be measured, a longitudinal
imaging providing a way through the heterogeneity. Future
developments of the method, extending the spectral range to
the ﬁngerprint region, replacing H2O with D2O to reduce the
spectral overlap, and combining CARS and SRS to optimize
sensitivity, are expected to improve the errors in the extracted
density distributions, to a level which allows to study cell
metabolism and the cell cycle in even more detail, in a label-
free manner. Notably, such studies typically require the
analysis of a large number of cells to gain statistical relevance,
Table 2. Results of the Volumetric Calculations of *1, *2,
and *3 of Taxol Treated Cellsa
i type γi
d Vi (μm
3) Vi/VROI (%) Mi (pg)
Figure 4 - Taxol - chromosomal volume - 1114 μm3 (27%)
1 P 0.312 44.6 ± 0.4 4.00 58.0 (66.8)
2 D 0.127 13 ± 2 1.15 19.2 (10.4)
3 L 0.753 19.2 ± 0.2 1.72 17.2
Figure 4 - Taxol - cell volume - 4174 μm3
1 P 0.312 191 ± 2 4.57 248.0 (285.7)
2 D 0.127 32 ± 2 0.77 48.1 (10.4)
3 L 0.753 97 ± 1 2.32 86.7
Figure S14 - Taxol - chromosomal volume - 1001 μm3 (19%)
1 P 0.312 43.8 ± 0.4 4.38 57.0 (65.7)
2 D 0.127 12 ± 2 1.16 17.4 (8.8)
3 L 0.753 20.4 ± 0.2 2.04 18.3
Figure S14 - Taxol - cell volume - 5273 μm3
1 P 0.312 259 ± 2 4.92 337.0 (388.2)
2 D 0.127 40 ± 3 0.76 60.0 (8.8)
3 L 0.753 146 ± 2 2.77 130.7
aThe rebalanced masses M̃P and M̃D are given in parentheses.
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which provides a further challenge to the technology which is
presently pursued.25 Following the proof-of-principle demon-
stration in the present work, focused studies answering speciﬁc
biological questions, such as eﬀect of topo II inhibition
molecules on chemical changes in the nucleolus, could be
commenced. Furthermore, applications of the demonstrated
noninvasive quantitative volumetric chemical imaging, with
picogram mass and submicrometer spatial resolution, are
ubiquitous also in other ﬁelds, such as material science and
pharmacology.
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